Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The companys products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal drinks, among others. It also provides healthcare supplements, Chinese herbal medicine and pharmaceutical medicines, among others. XPH offers services such as industrial chain services, research and development services, procurement, manufacturing, delivering services and distribution services, among others. The company provides its products and services to healthcare and medical care sectors. It has its operations in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia, China. XPH is headquartered in Guangzhou, China.

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12
Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13
Licensing Agreements 14
Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14
Equity Offering 16
Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16
Debt Offering 17
Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17
Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18
Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19
Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20
Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21
Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22
Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For US$86.1 Million 23
Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To US$95.05 Million 24
Acquisition 25
Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25
Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26
Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27
Xiangxue Pharma To Acquire 70% Stake In China-Based Company For US$73.7 Million 28
Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For US$0.03 Million 29
Xiangxue Pharma Acquires 52% Stake In China-Based Company For US$4.1 Million 30
Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For US$2.4 Million 31
Xiangxue Pharmaceutical Co Ltd - Key Competitors 32
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Other Significant Developments 34
Jun 07, 2018: GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List Of Tables


Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xiangxue Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xiangxue Pharma Signs Agreement with GE Medical Systems Trade & Development 12
Xiangxue Pharma Plans to Form Joint Venture in Guangzhou City 13
Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 14
Xiangxue Pharma Raises USD259 Million in Rights Offering of Shares 16
Xiangxue Pharmaceutical Raises USD31.7 Million in Public Offering of Bonds 17
Xiangxue Pharma Raises USD75.6 Million in Public Offering of Bonds 18
Xiangxue Pharma Plans to Raise up to USD75.3 Million in Private Placement of Bonds Due 2022 19
Xiangxue Pharma Raises USD90.2 Million in Public Offering of Bonds 20
Xiangxue Pharma Plans to Raise up to USD188.5 Million in Public Offering of Bonds 21
Xiangxue Pharma Raises USD112 Million in First Tranche Public Offering of 3.39% Notes Due 2017 22
Xiangxue Pharma Announces Private Placement Of Bonds Due 2017 For US$86.1 Million 23
Xiangxue Pharma Announces Public Offering Of Corporate Bonds For Up To US$95.05 Million 24
Xiangxue Pharma Plans to Acquire Stake in a Biotechnology Firm for USD7.1 Million 25
Xiangxue Pharma to Acquire 60% Stake in Guangzhou Based Pharma Company 26
Xiangxue Pharma Plans to Acquire 55% Stake in Hubei Ji day Chinese Herbal Medicine for USD55 Million 27
Xiangxue Pharma To Acquire 70% Stake In China-Based Company For US$73.7 Million 28
Xiangxue Pharma Plans To Acquire 25% Stake In China-Based Company For US$0.03 Million 29
Xiangxue Pharma Acquires 52% Stake In China-Based Company For US$4.1 Million 30
Xiangxue Pharma Plans To Acquire 7.98% Stake In China-Based Company For US$2.4 Million 31
Xiangxue Pharmaceutical Co Ltd, Key Competitors 32
Xiangxue Pharmaceutical Co Ltd, Subsidiaries 33

List Of Figures


Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xiangxue Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xiangxue Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The companys products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal

USD 250 View Report

Xiangxue Pharmaceutical Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Xiangxue Pharmaceutical Co, Ltd Company Profile is a detailed strategic and analytical report on Xiangxue Pharmaceutical Co, Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Organ-On-Chip (OOC) Global Market Opportunities And Strategies To 2023 Including: By Organ Type: Lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain-barrier-on-chip, other organ models By Application: drug discovery, toxicology research, molecular biology, disease modelling, food safety, other applications By End-User: Academics, Biopharmaceutical Companies, Food & Beverages, Other Commercial industries By Products & Services: Devices, Testing Services By Type Of Material: Polymer, PDMS, Glass, Silicon Covering: Emulate Inc., AxoSim Inc., Kirkstall, TissUse GmbH, Nortis Inc.

Organ-On-Chip (OOC) Global Market Opportunities And Strategies To 2023 Including: By Organ Type: Lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain-barrier-on-chip, other organ models By Application: drug discovery, toxicology research, molecular biology, disease modelling, food safety, other applications By End-User: Academics, Biopharmaceutical Companies, Food & Beverages, Other Commercial industries By Products & Services: Devices, Testing Services By Type Of Material: Polymer, PDMS, Glass, Silicon Covering: Emulate Inc., AxoSim Inc., Kirkstall, TissUse GmbH, Nortis Inc. market research report available in single user pdf license with Aarkstore Enterprise at USD 4000

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available